You are here: Industry Insights > Glenmark

News List

Glenmark’s Saldanha takes over as president of IPA expressbpd
October 18, 2017
Glenn Saldanha, CMD, Glenmark Pharmaceuticals has taken over as the President of IPA for 2017-19. Rajesh Jain, Joint MD, Panacea Biotec has been appointed as the VP.
Glenmark gets US FDA nod for Aprepitant nausea capsules expressbpd
October 17, 2017
The tablets are generic versions of Merck Sharp and Dohme Corporation’s Emend capsules
Glenmark receives ANDA approval for Triamcinolone Acetonide Ointment expressbpd
August 24, 2017
It is the generic version of Kenalog Ointment, 0.1 per cent, of Mylan Pharmaceuticals
Glenmark’s Acyclovir Ointment USP, 5% receives ANDA approval expressbpd
August 03, 2017
Acyclovir Ointment USP, 5 per cent is the generic version of Zovirax Ointment, 5 per cent
Glenmark reports positive data in Phase 2a Study of GBR 830 expressbpd
August 02, 2017
GBR 830 is an investigational, first-in-class, Anti-OX40 Monoclonal Antibody
Glenmark’s consolidated revenue increases by 19 per cent expressbpd
July 31, 2017
Consolidated net profit and EBITDA increased by 47.01 per cent and 30.27 per cent respectively
Glenmark secures UK MHRA approval for anti-malarial medication pharmaceutical-technology
July 06, 2017
Glenmark Pharmaceuticals Europe (Glenmark) has secured final approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Maloff Protect, its range of atovaquone / proguanil film-coated tablets.
Glenmark receives MHRA, UK approval for Maloff Protect financialexpress
July 05, 2017
Maloff Protect is the first OTC approval granted by MHRA, which will be used for the prevention of malaria in adults
Glenmark receives MHRA, UK approval for Maloff Protect expressbpd
July 05, 2017
Maloff Protect is the first OTC approval granted by MHRA, which will be used for the prevention of malaria in adults
Glenmark Receives ANDA Approval for Indomethacin americanpharmaceuticalreview
June 29, 2017
Glenmark Pharmaceuticals has been granted final Abbreviated New Drug Application (ANDA) approval by the United States Food & Drug Administration (U.S. FDA) for Indomethacin Extended-Release Capsules USP, 75 mg,

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page